1. Home
  2. INBX vs LGI Comparison

INBX vs LGI Comparison

Compare INBX & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • LGI
  • Stock Information
  • Founded
  • INBX 2010
  • LGI 2004
  • Country
  • INBX United States
  • LGI United States
  • Employees
  • INBX N/A
  • LGI N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • LGI
  • Sector
  • INBX Health Care
  • LGI
  • Exchange
  • INBX Nasdaq
  • LGI Nasdaq
  • Market Cap
  • INBX 168.1M
  • LGI 189.3M
  • IPO Year
  • INBX 2020
  • LGI N/A
  • Fundamental
  • Price
  • INBX $11.18
  • LGI $15.52
  • Analyst Decision
  • INBX Hold
  • LGI
  • Analyst Count
  • INBX 1
  • LGI 0
  • Target Price
  • INBX N/A
  • LGI N/A
  • AVG Volume (30 Days)
  • INBX 97.5K
  • LGI 41.1K
  • Earning Date
  • INBX 05-20-2025
  • LGI 01-01-0001
  • Dividend Yield
  • INBX 7.56%
  • LGI 7.10%
  • EPS Growth
  • INBX N/A
  • LGI N/A
  • EPS
  • INBX 112.62
  • LGI N/A
  • Revenue
  • INBX $200,000.00
  • LGI N/A
  • Revenue This Year
  • INBX N/A
  • LGI N/A
  • Revenue Next Year
  • INBX N/A
  • LGI N/A
  • P/E Ratio
  • INBX $0.10
  • LGI N/A
  • Revenue Growth
  • INBX N/A
  • LGI N/A
  • 52 Week Low
  • INBX $10.80
  • LGI $12.66
  • 52 Week High
  • INBX $18.95
  • LGI $16.68
  • Technical
  • Relative Strength Index (RSI)
  • INBX 38.27
  • LGI 57.99
  • Support Level
  • INBX $10.90
  • LGI $15.34
  • Resistance Level
  • INBX $12.60
  • LGI $15.68
  • Average True Range (ATR)
  • INBX 0.86
  • LGI 0.25
  • MACD
  • INBX -0.03
  • LGI 0.12
  • Stochastic Oscillator
  • INBX 14.28
  • LGI 90.12

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About LGI Lazard Global Total Return and Income Fund

Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.

Share on Social Networks: